Guardian Pharmacy Services, Inc. (GRDN) intrinsic value & 10-year financials
Guardian Pharmacy Services, Inc. (GRDN) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 3 fiscal years revenue grew 17.9% a year to $1.4B, with an average return on invested capital of -9.2%.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $39.47
- Revenue (FY2025)
- $1.4B
- Revenue growth (3-yr CAGR)
- 17.9%
- ROIC (10-yr avg)
- -9.2%
- Free cash flow (FY2025)
- $86.8M
GRDN 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $1.4B | $49.2M | — | $86.8M | 5.0% | 27.1% |
| FY2024 | $1.2B | -$110.0M | — | $43.2M | -5.1% | -45.4% |
| FY2023 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Guardian Pharmacy Services, Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
Guardian Pharmacy Services, Inc. has historically struggled to out-earn its cost of capital, averaging just -9.2% ROIC.
Guardian Pharmacy Services, Inc. has not shown aggressive share repurchases (>10% retirement) or a major balance-sheet leverage increase (>50% net debt growth) over the 10-year window.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, Guardian Pharmacy Services, Inc. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment.